Ingalls Kerry D.

Insider profile

Performance

Overall performance
1.1

Performance over holding periods
1.1
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ingalls Kerry D.'s trades of Poseida Therapeutics, Inc.'s stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-03-18 2022-03-16 B Purchase
95,965 +41.9%
412.33
US$1,628,543
95,965 +41.9% 412.33 US$1,628,543
2021-11-18 2021-11-17 B Purchase
68,554 -5.5%
177.40
US$3,812,243
68,554 -5.5% 177.40 US$3,812,243